Divalent metal transporter, DMT1: A novel MRI reporter protein

Manganese (Mn)‐enhanced MRI (MEMRI) has found a growing number of applications in anatomical and functional imaging in small animals, based on the cellular uptake of Mn ions in the brain, heart, and other organs. Previous studies have relied on endogenous mechanisms of paramagnetic Mn ion uptake and...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance in medicine Vol. 70; no. 3; pp. 842 - 850
Main Authors Bartelle, Benjamin B., Szulc, Kamila U., Suero-Abreu, Giselle A., Rodriguez, Joe J., Turnbull, Daniel H.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.09.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Manganese (Mn)‐enhanced MRI (MEMRI) has found a growing number of applications in anatomical and functional imaging in small animals, based on the cellular uptake of Mn ions in the brain, heart, and other organs. Previous studies have relied on endogenous mechanisms of paramagnetic Mn ion uptake and enhancement. To genetically control MEMRI signals, we reverse engineered a major component of the molecular machinery involved in Mn uptake, the divalent metal transporter, DMT1. DMT1 provides positive cellular enhancement in a manner that is highly sensitive and dynamic, allowing greater spatial and temporal resolution for MRI compared to previously proposed MRI reporters such as ferritin. We characterized the MEMRI signal enhancement properties of DMT1‐expressing cells, both in vitro and in vivo in mouse models of cancer and brain development. Our results show that DMT1 provides an effective genetic MRI reporter for a wide range of biological and preclinical imaging applications. Magn Reson Med 70:842–850, 2013. © 2012 Wiley Periodicals, Inc.
Bibliography:NIH grant - No. R01 NS038461
ark:/67375/WNG-L30D3D7X-2
istex:DC9E22FF9BBFF96E7042530BEEAE16A219406CDD
ArticleID:MRM24509
NIH/NYU GPP program for Structural Biology
NYU Cancer Center Support Grant - No. NIH P30 CA0016087
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0740-3194
1522-2594
DOI:10.1002/mrm.24509